focus -WSS

focus

author：focus 2025-09-30 00:50:49 - browse：57

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： The U.S. needs a new definition of substance use “recovery”

knowledge

WSS

Recent heat wave in the Mediterranean caused by climate change: Study

Listen: Who gets the credit for GLP

Ionis has late

Intercept Pharmaceuticals sells itself for less than $1 billion

Would Medicare drug price negotiations stall in a shutdown?

Address the ethical violations that led to 'Three Identical Strangers'

focus

focus

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Parents surprise family after baby discharged from NICU after 170 days

DIEP, the 'gold standard' of breast reconstruction, is under threat

Intercept Pharmaceuticals sells itself for less than $1 billion

Malaria cases in Florida and Texas: Here’s what you need to know

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Tori Bowie and the unacceptable rates of Black maternal death

Kaiser Permanente unions announce official strike date

In age of alternative facts, a scholarly course on calling out crap

Create a giant ice tray with this foil pan hack to keep food cold this summer

explore

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Parents surprise family after baby discharged from NICU after 170 days

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

The aspartame in Diet Coke probably isn’t giving you cancer

FDA advisers vote against ALS treatment from BrainStorm

knowledge

focus

hotspot

leisure time